Evidence map›Paper›PMID 38762666›Full record

ArticleArchives of toxicology2024

A novel support vector machine-based 1-day, single-dose prediction model of genotoxic hepatocarcinogenicity in rats.

Min Gi, Shugo Suzuki, Masayuki Kanki, Masanao Yokohira, Tetsuya Tsukamoto, Masaki Fujioka, Arpamas Vachiraarunwong, Guiyu Qiu, Runjie Guo, Hideki Wanibuchi

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Min GiDepartment of Environmental Risk Assessment, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.ORCID 0000-0003-1642-8127
Shugo SuzukiDepartment of Molecular Pathology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.ORCID 0000-0001-8938-9670
Masayuki KankiDepartment of Molecular Pathology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Masanao YokohiraDepartment of Medical Education, Faculty of Medicine, Kagawa University, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.
Tetsuya TsukamotoDepartment of Diagnostic Pathology, Graduate School of Medicine, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.
Masaki FujiokaDepartment of Molecular Pathology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.ORCID 0000-0003-0048-2874
Arpamas VachiraarunwongDepartment of Environmental Risk Assessment, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.ORCID 0000-0002-0463-2289
Guiyu QiuDepartment of Molecular Pathology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Runjie GuoDepartment of Environmental Risk Assessment, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Hideki WanibuchiDepartment of Molecular Pathology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan. wani@omu.ac.jp.ORCID 0000-0001-9362-4290

Funding

Japan Society for the Promotion of Science 23K09652Ministry of Health, Labour and Welfare 20KD0101Ministry of Health, Labour and Welfare 22KD1003
6 · The paper itself

Abstract

The development of a rapid and accurate model for determining the genotoxicity and carcinogenicity of chemicals is crucial for effective cancer risk assessment. This study aims to develop a 1-day, single-dose model for identifying genotoxic hepatocarcinogens (GHCs) in rats. Microarray gene expression data from the livers of rats administered a single dose of 58 compounds, including 5 GHCs, was obtained from the Open TG-GATEs database and used for the identification of marker genes and the construction of a predictive classifier to identify GHCs in rats. We identified 10 gene markers commonly responsive to all 5 GHCs and used them to construct a support vector machine-based predictive classifier. In the silico validation using the expression data of the Open TG-GATEs database indicates that this classifier distinguishes GHCs from other compounds with high accuracy. To further assess the model's effectiveness and reliability, we conducted multi-institutional 1-day single oral administration studies on rats. These studies examined 64 compounds, including 23 GHCs, with gene expression data of the marker genes obtained via quantitative PCR 24 h after a single oral administration. Our results demonstrate that qPCR analysis is an effective alternative to microarray analysis. The GHC predictive model showed high accuracy and reliability, achieving a sensitivity of 91% (21/23) and a specificity of 93% (38/41) across multiple validation studies in three institutions. In conclusion, the present 1-day single oral administration model proves to be a reliable and highly sensitive tool for identifying GHCs and is anticipated to be a valuable tool in identifying and screening potential GHCs.

Indexed as

Support Vector MachineAdministration, OralAnimalsCarcinogenicity TestsCarcinogensGene Expression ProfilingLiverMaleMutagensOligonucleotide Array Sequence AnalysisRatsReproducibility of ResultsRisk AssessmentCarcinogensMutagensCarcinogenicity predictionGenotoxic hepatocarcinogenMarker genesRat modelSVM classifier

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.